Description
BLOOD AGAR PRODUCTS FOR LAB
First action · last action
2013-10-01 · 2014-11-05
Transactions
2
First transaction's obligation
$10,911
Base + all options value (sum of deltas)
$9,542
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
Parent IDV
V797P5992X
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-01+$10,911= $10,911
- Mod P000012014-11-05-$1,368= $9,542
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-01 | +$10,911 | $10,911 | BLOOD AGAR PRODUCTS FOR LAB |
| Mod P00001· CLOSE OUT | 2014-11-05 | −$1,368 | $9,542 | BLOOD AGAR PRODUCTS FOR LAB |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI F5TEGZ32EJ38)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526P0515 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $36,373 | FY2026 |
| 36C26126N0704 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $44,786 | FY2026 |
| 36C25726N0420 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $534,527 | FY2026 |
| 36C25726D0085 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $0 | FY2026 |
| 36C25226N0484 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $28,264 | FY2026 |
| 36C25726P0621 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $137,778 | FY2026 |
Other recipients under 6505 from 503-ALTOONA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24413F4115 | GRIFOLS THERAPEUTICS LLC | 503-ALTOONA | $37,405 | FY2014 |
| VA24413P2434 | ASD SPECIALTY HEALTHCARE, LLC | 503-ALTOONA | $13,162 | FY2013 |
| VA24413P1170 | ASD SPECIALTY HEALTHCARE, LLC | 503-ALTOONA | $13,020 | FY2013 |
| VA24413F3114 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 503-ALTOONA | $37,360 | FY2013 |
| VA24412P2702 | MCKESSON CORPORATION | 503-ALTOONA | $8,424 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24414F4202_3600_V797P5992X_3600 · retrieved 2026-09-26.